Decoquinate liposomes: highly effective clearance of Plasmodium parasites causing severe malaria
Abstract Background Severe malaria caused by Plasmodium falciparum leads to most malaria-related deaths globally. Decoquinate (DQ) displays strong activity against multistage infection by Plasmodium parasites. However, the development of DQ as an oral dosage form for the treatment of malaria at the...
Main Authors: | Sumei Zeng, Hongxing Wang, Long Tao, Xiaohui Ning, Yinzhou Fan, Siting Zhao, Li Qin, Xiaoping Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-01-01
|
Series: | Malaria Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12936-022-04042-8 |
Similar Items
-
Preliminary Assessment of Intramuscular Depot of Lipid-Based Decoquinate Formulation for Long-Term Chemoprophylaxis of Malaria
by: Yinzhou Fan, et al.
Published: (2022-12-01) -
The evaluation of ADME and pharmacokinetic properties of decoquinate derivatives for the treatment of malaria
by: Daniel J. Watson, et al.
Published: (2022-08-01) -
Efficacy of the feed additive consisting of decoquinate (Deccox®) for use in chickens for fattening (Zoetis Belgium SA)
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Published: (2021-03-01) -
Chemical and Pharmacological Properties of Decoquinate: A Review of Its Pharmaceutical Potential and Future Perspectives
by: Tainá Santos Souza, et al.
Published: (2022-06-01) -
Scientific Opinion on the modification of the terms of authorisation of Avi‐Deccox® 60G (decoquinate) for chickens for fattening
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
Published: (2014-11-01)